SGMT offering history
Every offering-related filing in Sagimet Biosciences Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 253 filings back to May 8, 2007.
| Date | Filing | What it means | |
|---|---|---|---|
| Apr 28, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 14, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 26, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 15, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 29, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jan 25, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 24, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jan 23, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jul 17, 2023 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jul 13, 2023 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Jul 13, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 10, 2023 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jul 3, 2023 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jun 23, 2023 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Mar 21, 2022 | RW → | WITHDRAWN | Registration withdrawn |
| May 10, 2021 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Apr 16, 2021 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
SGMT offering FAQ
When did SGMT last execute an offering?
Per SEC filings, Sagimet Biosciences Inc.'s most recent priced offering document is a 424B5 filed 2026-04-28. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did SGMT last announce or register an offering?
The most recent registration is a S-3 filed 2024-08-15. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.